Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Astrid Z Johansen

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Scientific Reports|January 14, 2021
Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumabNeel I Nissen, Stephanie Kehlet, Mogens K Boisen, et al.
Frontiers in Molecular Biosciences|March 27, 2023
High serum levels of the C-propetide of type V collagen (PRO-C5) are prognostic for short overall survival in patients with pancreatic ductal adenocarcinomaNeel I Nissen, Astrid Z Johansen, Inna M Chen, et al.
International Journal of Cancer|March 9, 2021
Noninvasive prognostic biomarker potential of quantifying the propeptides of Type XI collagen alpha-1 chain (PRO-C11) in patients with pancreatic ductal adenocarcinomaNeel Ingemann Nissen, Stephanie Kehlet, Astrid Z Johansen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 6, 2019
Prognostic Value of Combined Detection of Serum IL6, YKL-40, and C-reactive Protein in Patients with Unresectable Pancreatic CancerInna M Chen, Astrid Z Johansen, Christian Dehlendorff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2021
Circulating Protein Biomarkers for Use in Pancreatic Ductal Adenocarcinoma IdentificationSidsel C Lindgaard, Zsófia Sztupinszki, Emil Maag, et al.
International Journal of Cancer|October 24, 2019
Clinical value of serum hyaluronan and propeptide of type III collagen in patients with pancreatic cancerInna M Chen, Nicholas Willumsen, Christian Dehlendorff, et al.
European Journal of Cancer Care|January 8, 2020
Prognostic impact of Charlson's Age-Comorbidity Index and other risk factors in patients with pancreatic cancerKarin Bagni, Inna M Chen, Astrid Z Johansen, et al.
Iscience|February 18, 2026
Integrating thermal liquid biopsy, clinical data, and mass spectrometry for early diagnosis and biomarker discovery in colorectal cancerSonia Hermoso-Durán, David Ortega-Alarcon, Astrid Z Johansen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2020
Serum IL6 as a Prognostic Biomarker and IL6R as a Therapeutic Target in Biliary Tract CancersDan Høgdall, Colm J O'Rourke, Christian Dehlendorff, et al.
European Journal of Cancer (Oxford, England : 1990)|December 20, 2020
Pre-treatment serum vitamin D deficiency is associated with increased inflammatory biomarkers and short overall survival in patients with pancreatic cancerLouise S Rasmussen, Mette K Yilmaz, Ursula G Falkmer, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Scientific Reports|January 14, 2021
Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumabNeel I Nissen, Stephanie Kehlet, Mogens K Boisen, et al.
Frontiers in Molecular Biosciences|March 27, 2023
High serum levels of the C-propetide of type V collagen (PRO-C5) are prognostic for short overall survival in patients with pancreatic ductal adenocarcinomaNeel I Nissen, Astrid Z Johansen, Inna M Chen, et al.
International Journal of Cancer|March 9, 2021
Noninvasive prognostic biomarker potential of quantifying the propeptides of Type XI collagen alpha-1 chain (PRO-C11) in patients with pancreatic ductal adenocarcinomaNeel Ingemann Nissen, Stephanie Kehlet, Astrid Z Johansen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 6, 2019
Prognostic Value of Combined Detection of Serum IL6, YKL-40, and C-reactive Protein in Patients with Unresectable Pancreatic CancerInna M Chen, Astrid Z Johansen, Christian Dehlendorff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2021
Circulating Protein Biomarkers for Use in Pancreatic Ductal Adenocarcinoma IdentificationSidsel C Lindgaard, Zsófia Sztupinszki, Emil Maag, et al.
International Journal of Cancer|October 24, 2019
Clinical value of serum hyaluronan and propeptide of type III collagen in patients with pancreatic cancerInna M Chen, Nicholas Willumsen, Christian Dehlendorff, et al.
European Journal of Cancer Care|January 8, 2020
Prognostic impact of Charlson's Age-Comorbidity Index and other risk factors in patients with pancreatic cancerKarin Bagni, Inna M Chen, Astrid Z Johansen, et al.
Iscience|February 18, 2026
Integrating thermal liquid biopsy, clinical data, and mass spectrometry for early diagnosis and biomarker discovery in colorectal cancerSonia Hermoso-Durán, David Ortega-Alarcon, Astrid Z Johansen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2020
Serum IL6 as a Prognostic Biomarker and IL6R as a Therapeutic Target in Biliary Tract CancersDan Høgdall, Colm J O'Rourke, Christian Dehlendorff, et al.
European Journal of Cancer (Oxford, England : 1990)|December 20, 2020
Pre-treatment serum vitamin D deficiency is associated with increased inflammatory biomarkers and short overall survival in patients with pancreatic cancerLouise S Rasmussen, Mette K Yilmaz, Ursula G Falkmer, et al.
Pageof 3